A detailed history of Jones Financial Companies Lllp transactions in Astrazeneca PLC stock. As of the latest transaction made, Jones Financial Companies Lllp holds 13,162 shares of AZN stock, worth $831,838. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,162
Previous 6,550 100.95%
Holding current value
$831,838
Previous $510,000 100.98%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$76.67 - $87.62 $506,942 - $579,343
6,612 Added 100.95%
13,162 $1.03 Million
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $309,530 - $374,485
4,633 Added 241.68%
6,550 $510,000
Q1 2024

May 14, 2024

BUY
$61.03 - $69.57 $86,113 - $98,163
1,411 Added 278.85%
1,917 $129,000
Q4 2023

Feb 13, 2024

BUY
$61.89 - $69.28 $14,544 - $16,280
235 Added 86.72%
506 $34,000
Q3 2023

Nov 14, 2023

SELL
$64.85 - $71.7 $47,924 - $52,986
-739 Reduced 73.17%
271 $18,000
Q2 2023

Aug 09, 2023

BUY
$69.91 - $75.81 $45,930 - $49,807
657 Added 186.12%
1,010 $72,000
Q1 2023

May 11, 2023

SELL
$63.15 - $71.6 $25,196 - $28,568
-399 Reduced 53.06%
353 $24,000
Q4 2022

Feb 13, 2023

SELL
$54.21 - $70.44 $162 - $211
-3 Reduced 0.4%
752 $50,000
Q2 2022

Aug 08, 2022

BUY
$59.26 - $71.14 $28,800 - $34,574
486 Added 180.67%
755 $50,000
Q1 2022

May 02, 2022

SELL
$55.72 - $67.12 $189,726 - $228,543
-3,405 Reduced 92.68%
269 $18,000
Q4 2021

Feb 11, 2022

BUY
$54.02 - $63.83 $174,484 - $206,170
3,230 Added 727.48%
3,674 $214,000
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $6,444 - $7,051
116 Added 35.37%
444 $27,000
Q2 2021

Aug 12, 2021

SELL
$48.42 - $60.18 $46,095 - $57,291
-952 Reduced 74.38%
328 $20,000
Q1 2021

Apr 30, 2021

BUY
$47.16 - $54.44 $41,547 - $47,961
881 Added 220.8%
1,280 $64,000
Q4 2020

Feb 08, 2021

BUY
$48.52 - $58.02 $19,359 - $23,149
399 New
399 $20,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $196B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.